Podcast
In conversation — Biomarker-guided therapy and the future of allergy and immunology
Date Published:
About this Podcast
Contrary to earlier assumptions, threshold harmonization is still an open question, although confirmatory data are still limited. Across multiple cohorts, variability between operators remains a key limitation, particularly in resource-constrained settings.
Register once for free access to all content, courses, podcasts, webinars, events and more.
Register to watch
Already have an account? Log in
